Zydus Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?
ZYDUS LIFESCIENCES has sixty-seven approved drugs.
There is one US patent protecting ZYDUS LIFESCIENCES drugs.
There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and one hundred and sixty-two supplementary protection certificates in sixteen countries.
Summary for Zydus Lifesciences
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 58 |
| Ingredients: | 58 |
| NDAs: | 67 |
Drugs and US Patents for Zydus Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 213055-003 | Sep 1, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | CLOBETASOL PROPIONATE | clobetasol propionate | LOTION;TOPICAL | 205249-001 | Sep 24, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077625-001 | Oct 16, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus Lifesciences | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 090411-002 | Jun 1, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zydus Lifesciences Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Try a Trial |
| Philippines | 12016501686 | ⤷ Try a Trial |
| South Africa | 201606075 | ⤷ Try a Trial |
| India | 651MU2014 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zydus Lifesciences Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1620113 | 56/2015 | Austria | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN; NAT. REGISTRATION NO/DATE: 136170 20150602; FIRST REGISTRATION: MT MA 117/01101 20150402 |
| 0459136 | C970044 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: CANDESARTAN, DESGENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF VAN DE 1-(CYCLOHEXYLOXYCARBONYLOXY) ETHYLESTE R, IN HET BIJZONDER CILEXETILI CANDESARTANAS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: RVG 21703 - RVG 21706 19971013; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
| 1412357 | 122007000056 | Germany | ⤷ Try a Trial | PRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE FUER SITAGLIPTINPHOSPHAT-MONOHYDRAT; REGISTRATION NO/DATE: EU/1/07/383/001-018 20070321 |
| 1412357 | 07C0041 | France | ⤷ Try a Trial | PRODUCT NAME: SITAGLIPTINE, EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET EN PARTICULIER LE PHOSPHATE DE SITAGLIPTINE MONOHYDRATE; REGISTRATION NO/DATE: EU/1/07/383/001 20070323 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
